The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.
about
Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancerValue of Cell Block in the Diagnosis of Malignant Pleural EffusionMutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature reviewNon-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerTumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectivesGuide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancerEmerging platforms using liquid biopsy to detect EGFR mutations in lung cancerLiquid biopsy genotyping in lung cancer: ready for clinical utility?A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR statusCUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to erlotinib via transcriptional regulation of EGFR.Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population.Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung CancerThe Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis.Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation statusDetection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung CancerEGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysisClinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks.Liquid Biopsy in Non-Small Cell Lung Cancer.EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.Diagnostic approach to pleural diseases: new tricks for an old trade.Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany.Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer.The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?Non-blood circulating tumor DNA detection in cancer.Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay.A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion.Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer.Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients.
P2860
Q26775376-71B7EABA-5EFF-4FE9-8D1C-F2EFD8F97101Q26781679-09313146-6EBD-4855-86A0-B2A8EC1554AAQ26785713-C73482DF-7A1F-4BAA-917C-055F893BEE6BQ26801357-1B1F42E8-ECCD-4DF2-8465-C81C3CD2384DQ27014117-C97A984B-ECCD-46D9-B410-B34BC60456A5Q28079253-755F1D67-ED81-498C-9E5A-9F26D8E2CEADQ28082499-A968371A-9181-48C6-A566-B85BE6BE1D89Q33567037-68EE6F5B-2EED-47DA-A9CF-259A65E79D0FQ34041754-8738255C-C954-4F6D-83F3-1D294FF0EF3AQ34473831-2EC274A7-C54A-4C0E-88A7-FA50D227C1E3Q34581688-6030DBEF-BBDE-40E4-AE06-382BBEFBECDDQ35028752-E22FE04A-8277-4DE0-94C0-EA541781F361Q35192525-6E0C7612-D8AE-4FBE-BF47-3E67C1B23B03Q35654703-8B2B8F99-7462-4496-A759-5CA9F439358CQ36095650-7B927B8E-C66B-4F78-A35C-EBD3625EE687Q36202696-235A6C03-7EE5-40EE-928F-914C08B15E99Q36375343-112E9EE8-26BE-4533-BFAC-C2232707F15FQ36643142-9FAD52EA-2177-4BAB-86C2-57E19F16F2E1Q37339704-F9084978-E37A-420D-8FED-277D40F82751Q37592893-71325C14-14CE-4B32-9ABA-3D4BBF79A1F4Q37743832-3875CAA7-9D53-499A-B640-379B694B8B63Q38694431-F6BC523D-A452-4FE3-9D59-5FB603B333B9Q38824891-B21E6A55-2ABD-47A7-BD69-86F07F562637Q38844281-0EB93755-3640-419B-9C59-88D30AB86A38Q38962364-23E302D4-DA3B-4B19-90E2-893EF5FAD2F1Q39076207-D5AFDB28-9D0E-4CA8-B68B-3725D1EA4D42Q39651867-23D6452A-318C-43AB-B52B-0C21E75C2520Q40104700-769A1AC4-E9FF-4134-B9D7-AC3E711D01C4Q40502030-590DDE75-E196-4D3E-9F27-CE8057271A1FQ40829674-68EE5C66-FC5B-41A6-B570-D064F90B24F2Q41260159-E0D77493-34E1-4A1E-A142-ACB338E4422CQ41472736-5AF5522D-7ACB-4001-85FA-2741BDE4A3C9Q41866575-922A953B-E29C-4729-A8FD-DAEF690C8589Q42253044-C7A48E8F-D2E3-424C-8430-C8A476747C26Q44658595-EE16737D-8D16-448A-95BF-240F1FE98535Q47134284-DCAB68CF-8D54-411D-BA63-9942A6BBD1D2Q47198852-A9149002-4CAB-438C-B03B-8FFD02AA5D67Q47563363-21F25338-0558-4D1C-8FD1-613A08E4C51FQ48502619-4CA7407D-FE23-44DB-826A-C48DD97B2369Q49450097-7F4D013C-6D3B-41B4-AC9E-EC38C8850EAE
P2860
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The diagnostic accuracy of ple ...... : comparison of methodologies.
@en
The diagnostic accuracy of ple ...... : comparison of methodologies.
@nl
type
label
The diagnostic accuracy of ple ...... : comparison of methodologies.
@en
The diagnostic accuracy of ple ...... : comparison of methodologies.
@nl
prefLabel
The diagnostic accuracy of ple ...... : comparison of methodologies.
@en
The diagnostic accuracy of ple ...... : comparison of methodologies.
@nl
P2093
P2860
P1476
The diagnostic accuracy of ple ...... : comparison of methodologies.
@en
P2093
Chuanhao Tang
Gillian Ellison
Guanshan Zhu
Haifeng Qin
Qunsheng Ji
Rose McCormack
Xiaoqing Liu
P2860
P304
P356
10.1136/JCLINPATH-2013-201728
P407
P577
2013-07-25T00:00:00Z